Cti Biopharma reported $-24179000 in Net Income for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Applied Genetic Technologies AGTC:US $ -14.29M 4.85M
Cytori Therapeutics CYTX:US $ -4.12M 0.04M
Geron GERN:US $ -30.1M 1.92M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Northwest Biotherapeutics NWBO:US -14214000 147.53M
Novartis NOVN:VX SF 16308M 13550M